Blog
Insights on using AI to search for the cure of cancer

The recent study from the University of Georgia has shed light on a troubling issue: individuals residing in low-income neighborhoods are significantly less likely to receive essential cancer...
Read more →
Addressing Disparities: The Urgent Need for Cancer Screenings in Low-Income Neighborhoods
April 29, 2026
A recent study from the University of Georgia has uncovered a troubling reality: individuals living in low-income neighborhoods are significantly less likely to receive cancer screenings at federal...
Read more →
New Risk Model Enhances Survival Predictions for Esophageal Cancer Patients Post-Surgery
April 29, 2026
Recent research utilizing the STS General Thoracic Surgery Database has unveiled a groundbreaking risk model that could significantly influence treatment decisions for patients undergoing...
Read more →
In a groundbreaking development for early cancer detection, researchers at Johns Hopkins have unveiled a novel approach that could significantly change the landscape of oncology diagnostics. By...
Read more →
Recent news has highlighted a troubling issue within the cancer research community: disruptions in federal funding are significantly slowing down critical studies aimed at developing new treatments...
Read more →
Revolutionizing Immunotherapy: The Promise of Atomically Engineered Nanozymes in Cancer Treatment
April 29, 2026
The recent breakthrough in cancer research, as reported by Newswise, introduces atomically engineered nanozymes (AENs)—tiny, engineered tools designed to enhance our immune system's ability to fight...
Read more →
Transforming Prostate Cancer Screening: New Guidelines Emphasize Patient Comfort and Precision
April 28, 2026
The recent announcement from the National Comprehensive Cancer Network (NCCN) about updated prostate cancer screening guidelines marks a pivotal shift in how healthcare providers approach this common...
Read more →
New NCCN Guidelines Highlight Less Invasive Prostate Cancer Screening: A Win for Patients
April 28, 2026
Recent updates in prostate cancer screening guidelines from the National Comprehensive Cancer Network (NCCN) mark a significant shift in how healthcare providers assess risk and detect this prevalent...
Read more →
The recent development of atomically engineered nanozymes (AENs) marks a significant milestone in the intersection of nanotechnology and immunotherapy, presenting an exciting frontier for cancer...
Read more →
Recent advancements in cancer treatment highlight the ongoing battle against one of the most challenging forms of cancer: pancreatic cancer. A recent study showcased the potential of an...
Read more →
In a significant breakthrough for cancer research, researchers at the Mayo Clinic have uncovered one of the key reasons why certain types of breast cancer resist treatment with a promising new...
Read more →
Recent findings from researchers at the Mayo Clinic are shedding light on a critical issue in breast cancer treatment: the resistance some patients exhibit to a promising class of therapies known as...
Read more →
Navigating Resistance in Breast Cancer Treatment: Insights from Mayo Clinic's Recent Discovery
April 27, 2026
In the ever-evolving landscape of cancer treatment, a recent breakthrough from the Mayo Clinic has shed light on a critical aspect of breast cancer therapy. Researchers have identified a key reason...
Read more →
New Insights into Breast Cancer Resistance Open Doors for Personalized Treatment Approaches
April 27, 2026
Recent breakthroughs in cancer research continue to provide hope for patients battling breast cancer, and a new study from the Mayo Clinic has shed light on a significant challenge: the resistance of...
Read more →
NCCN's Annual Commitment to Patient Resources: A Step Towards Empowering Cancer Patients
April 27, 2026
On February 4, 2026, World Cancer Day, the National Comprehensive Cancer Network (NCCN) announced a significant commitment to enhancing the resources available to cancer patients and caregivers. This...
Read more →
Unlocking the Future of Radiation Oncology: The Role of AI in Cancer Treatment Innovation
April 27, 2026
On World Cancer Day 2026, the American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) emphasized the vital role of modern radiation therapy in...
Read more →
Unlocking the Potential of Modern Radiotherapy: A Unified Call for Innovation on World Cancer Day 2026
April 27, 2026
On World Cancer Day 2026, the American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) have come together to emphasize the critical role of...
Read more →
The landscape of cancer treatment is continually evolving, and recent developments shine a light on the potential for innovative therapies to improve patient outcomes. A historic clinical trial using...
Read more →
Revolutionizing Cancer Care: Nigeria's First Immunotherapy Clinical Trial for Colorectal Cancer
April 26, 2026
In a significant milestone for cancer research and treatment, Nigeria is now enrolling patients in its first clinical trial utilizing immunotherapy for colorectal cancer. This groundbreaking...
Read more →
PhotonPharma Inc. Begins Phase 1 Trial of Innocell™: A New Hope for Recurrent Epithelial Ovarian Cancer
April 26, 2026
On February 5, 2026, PhotonPharma Inc., a biopharmaceutical company at the forefront of personalized cancer immunotherapies, announced the opening of patient recruitment for its Phase 1 clinical...
Read more →